ICL Raises 2026 Profit Outlook After Strong Q1 on Potash and Bromine

Overview

• ICL reported Q1 2026 sales of $2.0 billion, up 14%, with adjusted net income up 26% to $139 million and adjusted EBITDA up 15% to $412 million.
• The company lifted its full‑year EBITDA guidance by $100 million to a range of $1.5 billion to $1.7 billion, pointing to stronger demand and pricing.
• Potash, a key crop nutrient, saw sales jump nearly 25% with segment EBITDA up more than 45%, and bromine pricing was the strongest since late 2022.
• ICL completed the purchase of about 50% of a biotech ingredients business and opened its first specialty fertilizer plant in India to expand higher‑margin specialties.
• Management warned that rising sulfur costs and a stronger Israeli shekel could raise expenses and reduce reported profit.